Navigation Links
AACR-NCI-EORTC to hold molecular targets meeting in San Francisco
Date:11/9/2011

SAN FRANCISCO -- Progress in oncology drug development will take center stage Nov. 12-16, 2011, as thousands of scientists and industry experts convene at the Moscone Center West in San Francisco for the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics.

"During the last few years, numerous innovative agents have been discovered as a result of tremendous developments in the understanding of the molecular basis of cancer," said program co-chairperson Kenneth C. Anderson, M.D., Kraft Family professor of medicine and program director and chief of the division of hematologic neoplasia at Dana-Farber Cancer Institute and Harvard Medical School. "The level of excitement surrounding targeted therapy and the high caliber of the science to be presented fuel the power of this meeting to attract the world's leaders in cancer therapeutics."

Anderson, who is also editor in chief of Clinical Cancer Research, a journal of the American Association for Cancer Research, will host a press conference on new research in breast cancer at 7:00 a.m. PT on Sunday, Nov. 12.

The press conference will feature the following research:

HDAC Inhibitor May Overcome Resistance to Common Breast Cancer Drug

Benefit of Novel Drug in Breast Cancer Seen in Blood Within Weeks

Signaling Pathway Linked to Inflammatory Breast Cancer May Drive Disease Metastasis

On Nov. 12 at 11:00 a.m. PT, program co-chairperson James H. Doroshow, M.D., FACP, deputy director for clinical and translational research at the National Cancer Institute, will host a press conference on progress in angiogenesis.

The press conference will feature the following research:

Researchers Develop More Effective Way to Discover and Test Potential Cancer Drugs

Novel Monoclonal Antibody Offers Potential Treatment for Tumors Resistant to VEGF Therapy

Combination Therapy Shows Potent Tumor Growth Inhibition in Preclinical Studies

Both press conferences will take place in Room 2004 of the Moscone Center. Reporters who cannot attend in person can call in using the following information:

U.S./Canada: 888-647-7462

International: 201-604-0169

In addition to the press conference, the program chairpersons have designated the following research projects as newsworthy:

Antifolates Show Promise Against NSCLC Subtype

New Approaches May Prevent Certain Side Effects in BRAF Mutation-Positive Melanoma

Panel of Melanoma Mutations Opens Door to New Treatment Possibilities


'/>"/>
Contact: Jeremy Moore
Jeremy.Moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Molecular pathways linked to sex, age affect outcomes in lung cancer
2. SNMs Conjoint Mid-Winter Meetings continue to advance molecular imaging
3. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
4. The Association for Molecular Pathology celebrates ruling in DNA patent case
5. USC researchers discover new molecular subtype of brain cancer
6. Molecular discovery points to new therapies for brain tumors
7. Molecular marker could help spot pancreatic cancer early
8. News from Molecular Medicine
9. Scientists discover the molecular heart of collective behavior
10. Salt Lake City proclaims Molecular Imaging Days during SNMs Annual Meeting in June
11. Acupunctures molecular effects pinned down
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Clarion Safety Systems ... safety labels , has been featured in the National Electrical Manufacturers Association’s (NEMA) ... provides electroindustry professionals with manufacturer, regulatory, and standardization news. The publication is a ...
(Date:5/24/2016)... ... May 24, 2016 , ... Researchers from Catholic ... designed to reduce bleeding complications from percutaneous coronary intervention (PCI). The data, presented ... in Orlando, FL, document a 40% reduction in risk-adjusted bleeding event rates over ...
(Date:5/24/2016)... ... May 24, 2016 , ... Applications ... multiplex immunoassays are widely used for cell and protein analysis. Keeping updated on ... quality and efficiency in these areas. , LabRoots introduces a new complementary ...
(Date:5/23/2016)... ... ... Edward D. Buckingham, M.D . is excited announce that he has been ... out by the National Consumer Advisory Board to honor excellence in medicine. Only doctors ... award. , The National Consumer Advisory Board (NCAB) is a private organization created to ...
(Date:5/23/2016)... TX (PRWEB) , ... May 23, 2016 , ... ... to announce the participation of high-level representatives from the Japan PMDA, US FDA, ... discussions will address how CDISC standards help format data from clinical trials so ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... Een app die artsen over ... patiënten kunnen behandelen, hun kennis kunnen delen en van ... nieuwe en revolutionaire MDLinking App, ontwikkeld door een internationale ... Hans Flu en oncologisch chirurg dr. Gijs van ... wordt op dinsdag 24 mei officieel gepresenteerd op het ...
(Date:5/23/2016)... Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today the ... The hands-on learning experience is a 12-week summer program, ... Fellowship and Internship programs bring participants ... interns are provided optional housing free of charge through ... the Riverfront Residence Hall to foster communication and collaboration ...
(Date:5/23/2016)... , May 23, 2016 ... Devices, Diagnostics and Monitoring, and Vision Care ... Which areas are going to grow at the fastest ... revenues to 2026, assessing data, trends, opportunities and prospects. ... charts, and graphs. Discover the most lucrative areas in ...
Breaking Medicine Technology: